Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?

Is Cannabidiol During Neurodevelopment a Promising Therapy for Schizophrenia and Autism Spectrum Disorders?

Schizophrenia and autism spectrum disorders (ASD) are psychiatric neurodevelopmental disorders that cause high levels of functional disabilities. Also, the currently available therapies for these disorders are limited. Therefore, the search for treatments that could be beneficial for the altered cou...

Full description

Bibliographic Details
Main Authors:	Cássio Morais Loss, Lucas Teodoro, Gabriela Doná Rodrigues, Lucas Roberto Moreira, Fernanda Fiel Peres, Antonio Waldo Zuardi, José Alexandre Crippa, Jaime Eduardo Cecilio Hallak, Vanessa Costhek Abílio
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Pharmacology
Subjects:	cannabidiol Cannabidivarin schizophrenia Autism neurodevelopmental disorders Prodrome
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2020.635763/full

Similar Items

Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy
by: Fernanda Fiel Peres, et al.
Published: (2016-09-01)

Effects of Cannabinoid Drugs on the Deficit of Prepulse Inhibition of Startle in an Animal Model of Schizophrenia: the SHR Strain
by: Raquel eLevin, et al.
Published: (2014-02-01)

Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
by: Fernanda Fiel Peres, et al.
Published: (2016-09-01)

∆9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
by: José Alexandre Crippa, et al.
Published: (2016-09-01)

Human experimental anxiety: actual public speaking induces more intense physiological responses than simulated public speaking
by: Antonio Waldo Zuardi, et al.
Published: (2013-09-01)

Fifty years of research on cannabidiol as an anticonvulsant: the legacy of Brazilian groups
by: Antonio Waldo Zuardi, et al.
Published: (2024-02-01)

Marijuana, feijoada and the debate on drug legalization
by: José Alexandre eCrippa, et al.
Published: (2013-03-01)

Cannabis sativa: a planta que pode produzir efeitos indesejáveis e também tratá-los Cannabis sativa: the plant that can induce unwanted effects and also treat them
by: Antonio Waldo Zuardi, et al.
Published: (2010-05-01)

Uso terapêutico dos canabinoides em psiquiatria Therapeutical use of the cannabinoids in psychiatry
by: José Alexandre S. Crippa, et al.
Published: (2010-05-01)

Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
by: Fernanda F. Peres, et al.
Published: (2018-05-01)

Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930–March 9, 2023) and his legacy for Brazilian pharmacology
by: José Alexandre S. Crippa, et al.
Published: (2023-07-01)

Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
by: Fernanda F. Peres, et al.
Published: (2018-08-01)

Progression of the COVID-19 pandemic, Brazilian healthcare workers’ emotional burden and the effects on professional fulfillment at the end of the third wave: a longitudinal study
by: Sonia Regina Loureiro, et al.
Published: (2023-11-01)

Risk and Protective Factors for the Mental Health of Brazilian Healthcare Workers in the Frontline of COVID-19 Pandemic
by: Flávia L. Osório, et al.
Published: (2021-07-01)

An Evaluation of Understudied Phytocannabinoids and Their Effects in Two Neuronal Models
by: Alex Straiker, et al.
Published: (2021-09-01)

Mental health trajectories of Brazilian health workers during two waves of the COVID-19 pandemic (2020–2021)
by: Flávia de Lima Osório, et al.
Published: (2023-03-01)

Monitoring the Mental Health and Professional Overload of Health Workers in Brazil: A Longitudinal Study Considering the First Wave of the COVID-19 Pandemic
by: Flávia L. Osório, et al.
Published: (2022-04-01)

Cannabidiol induces autophagy via ERK1/2 activation in neural cells
by: Talita A. M. Vrechi, et al.
Published: (2021-03-01)

Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
by: Antonio W. Zuardi, et al.
Published: (2017-05-01)

Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD) Desempenho de pacientes esquizofrênicos no Stroop Color Word Test e responsividade eletrodérmica após administração aguda de canabidiol (CBD)
by: Jaime E. C. Hallak, et al.
Published: (2010-03-01)

Workplace Protections and Burnout Among Brazilian Frontline Health Care Professionals During the COVID-19 Pandemic
by: Karina Pereira-Lima, et al.
Published: (2022-04-01)

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action Canabidiol: de um canabinóide inativo a uma droga com amplo espectro de ação
by: Antonio Waldo Zuardi
Published: (2008-09-01)

No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
by: Ila M. P. Linares, et al.
Published: (2018-04-01)

Avaliação do papel do sistema canabidiol em um modelo de lesão renal por isquemia/reperfusão em animais
by: Rodrigo Zon Soares, et al.
Published: (2015-12-01)

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
by: Zuardi A.W., et al.
Published: (2006-01-01)

Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats
by: Erica Zamberletti, et al.
Published: (2019-08-01)

Plataformas digitais e uberização: a globalização de um Sul administrado?
by: Ludmila Costhek Abílio
Published: (2020-04-01)

Labour makeup: a case study of 800,000 cosmetics resellers in Brazil
by: Ludmila Costhek Abilio
Published: (2011-06-01)

Structure–Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives
by: Marcus R. Götz, et al.
Published: (2019-11-01)

Case Report: Cannabidiol-Induced Skin Rash: A Case Series and Key Recommendations
by: José Diogo S. Souza, et al.
Published: (2022-05-01)

Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
by: Carolina de Meneses-Gaya, et al.
Published: (2020-10-01)

Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression
by: Naoki Amada, et al.
Published: (2013-11-01)

Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
by: José A. Crippa, et al.
Published: (2018-09-01)

Expectativa de desempenho social de pacientes psiquiátricos internados em hospital geral Social performance expectations in psychiatric patients of a general hospital ward
by: Maria Stela Setti Moreira, et al.
Published: (2002-12-01)

Expectativa de desempenho social de pacientes psiquiátricos internados em hospital geral
by: Maria Stela Setti Moreira, et al.

Expectativa de desempenho social de pacientes psiquiátricos internados em hospital geral
by: Maria Stela Setti Moreira, et al.
Published: (2002-12-01)

Is the Fagerström Test for Nicotine Dependence a good instrument to assess tobacco use in patients with schizophrenia? O Teste de Fagerström para Dependência de Nicotina é um bom instrumento para avaliar o uso de tabaco em pacientes com esquizofrenia?
by: Carolina Menezes-Gaya, et al.
Published: (2009-09-01)

Expectativa de desempenho social de pacientes psiquiátricos internados em hospital geral
by: Moreira Maria Stela Setti, et al.
Published: (2002-01-01)

Systemic Chronic Treatment with Cannabidiol in Carioca High- and Low-Conditioned Freezing Rats in the Neuropathic Pain Model: Evaluation of Pain Sensitivity
by: Carolina Macêdo-Souza, et al.
Published: (2023-07-01)

Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae
by: Fan Yang, et al.
Published: (2022-12-01)